up the stock will plummet below $1.
might go below $1. Market doesnt seem to be impressed with the company and its products. Stock price ove the past few weeks speaks for itself.
and a good report on recent trial results. No good reason for the free fall.
It will repeat itself
continued downward slope. volume has dried up with little interest. If investors had confidence in the drugs the stock should already start to reflect that no matter what the stock price is.
will begin soon. Another CPXX in the making.
CTIX has 3 drugs in the pipeline.
we pull back to the low $1 range until the next trial results come in.